Skip to main content

Herter & Co. advises Halder portfolio company Amoena on its refinancing

By 13. February 2023March 21st, 2023No Comments

Herter & Co. has acted as Sole Debt Advisor on the refinancing of Amoena Group („Amoena“). Amoena was acquired in 2014 by funds advised by Halder and is the world market leader in high-quality medical breast care products for women who have undergone breast surgery.

Herter & Co. coordinated the refinancing of the existing LBO debt. The company’s solid performance during and post-Covid, the strong strategy and positive outlook as well as strong cash flow profile ensured banking support for a maturity extension and refinancing of the business at attractive terms.

„In order to ensure the financing of our future growth and maintain a healthy liquidity profile, we have successfully prolonged, rearranged and simplified our debt financing structure. Herter & Co. provided us with professional support throughout the whole process, including finding an appropriate financing structure, negotiations and communication with all financing parties and final documentation.“, said Oliver Dörner, CEO at Amoena.

“We are very happy with Herter & Co.’s high quality work and the results achieved. This allows us sufficient leeway to further advance the strategic positioning of the company and to set the course for the future.”, said Anja Böhme, Investment Director of Halder.

Herter & Co. acted as Sole Debt Adviser to Amoena.

Founded in 1975, Amoena focuses on breast care technology and innovation and launched the world’s first silicone-filled breast form. Since then, the company’s silicone breast forms have defined the world market standard and continue to evolve through ongoing research. The main markets are Europe and North America, with strong growth potential in Asia. The company covers the entire patient journey with breast forms, breast care apparel, and recovery care products including post-operative compression bras and silicone products for scar therapy.

Halder has been active as a private equity firm in the German-speaking countries since 1991, investing mainly in mid-sized companies in the industrial, healthcare and food & beverages sectors. Halder supports its portfolio companies on their way to market leadership. Over the past 30 years, Halder has invested in 45 companies and successfully completed 24 successions. The Halder team currently manages a portfolio of eight investments.